Long-Term Outcomes Following Heart Team Revascularization Recommendations in Complex Coronary Artery Disease.
Age Factors
Aged
Aged, 80 and over
Cardiology
Cardiovascular Agents
/ therapeutic use
Clinical Decision-Making
/ methods
Cooperative Behavior
Coronary Artery Bypass
Coronary Artery Disease
/ epidemiology
Female
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Patient Care Team
Percutaneous Coronary Intervention
Prospective Studies
Severity of Illness Index
Shock, Cardiogenic
/ epidemiology
Survival Rate
Thoracic Surgery
United Kingdom
Ventricular Dysfunction, Left
/ epidemiology
Heart Team
coronary artery disease
health outcomes
medication therapy
revascularization
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
16 04 2019
16 04 2019
Historique:
entrez:
5
4
2019
pubmed:
5
4
2019
medline:
24
7
2020
Statut:
ppublish
Résumé
Background The Heart Team ( HT ) comprises integrated interdisciplinary decision making. Current guidelines assign a Class Ic recommendation for an HT approach to complex coronary artery disease ( CAD ). However, there remains a paucity of data in regard to hard clinical end points. The aim was to determine characteristics and outcomes in patients with complex CAD following HT discussion. Methods and Results This observational study was conducted at St Thomas' Hospital (London, UK). Case mixture included unprotected left main, 2-vessel (including proximal left anterior descending artery) CAD , 3-vessel CAD , or anatomical and/or clinical equipoise. HT strategy was defined as optimal medical therapy ( OMT ) alone, OMT +percutaneous coronary intervention ( PCI ), or OMT +coronary artery bypass grafting. From April 2012 to 2013, 51 HT meetings were held and 398 cases were discussed. Patients tended to have multivessel CAD (74.1%), high SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) scores (median, 30; interquartile range, 23-39), and average age 69±11 years. Multinomial logistic regression analysis performed to determine variables associated with HT strategy demonstrated decreased likelihood of undergoing PCI compared with OMT in older patients with chronic kidney disease and peripheral vascular disease. The odds of undergoing coronary artery bypass grafting compared with OMT decreased in the presence of cardiogenic shock and left ventricular dysfunction and increased in younger patients with 3-vessel CAD . Three-year survival was 60.8% (84 of 137) in the OMT cohort, 84.3% (107 of 127) in the OMT + PCI cohort, and 90.2% in the OMT +coronary artery bypass grafting cohort (92 of 102). Conclusions In our experience, the HT approach involved a careful selection process resulting in appropriate patient-specific decision making and good long-term outcomes in patients with complex CAD .
Identifiants
pubmed: 30943827
doi: 10.1161/JAHA.118.011279
pmc: PMC6507188
doi:
Substances chimiques
Cardiovascular Agents
0
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e011279Subventions
Organisme : British Heart Foundation
ID : CS/16/3/32615
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/14/11/30526
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/16/51/32365
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Références
J Am Coll Cardiol. 2011 Dec 6;58(24):e44-122
pubmed: 22070834
JACC Cardiovasc Interv. 2010 Jan;3(1):22-31
pubmed: 20129564
J Am Heart Assoc. 2019 Apr 16;8(8):e011279
pubmed: 30943827
Circulation. 2000 Jun 20;101(24):2795-802
pubmed: 10859284
N Engl J Med. 2009 Mar 5;360(10):961-72
pubmed: 19228612
J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98
pubmed: 22958960
Lancet. 2011 May 28;377(9780):1836
pubmed: 21621715
Circ Cardiovasc Qual Outcomes. 2012 May;5(3):410-3
pubmed: 22592755
Circ Cardiovasc Qual Outcomes. 2013 Sep 1;6(5):598-603
pubmed: 24021700
JACC Cardiovasc Interv. 2010 Sep;3(9):891-901
pubmed: 20850087
Catheter Cardiovasc Interv. 2013 Apr;81(5):748-58
pubmed: 23197438
Int J Cardiol. 2016 Mar 1;206:37-41
pubmed: 26774827